Frank Gibbons
5PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 27, 2022
Hallmarks of neurodegenerative disease: A systems pharmacology perspective.Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan
|May 26, 2022
A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models.Dharaminder Singh, Sudhir P Deosarkar, Elaine Cadogan
|Jan 26, 2021
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy.Claire M Patterson, Srividya B Balachander, Iain Grant
|Dec 04, 2020
AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib.Vikki Flemington, Emma J Davies, David Robinson
|Sep 29, 2020
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.Srividya B Balachander, Steven W Criscione, Kate F Byth
Pageof 1
Frequent Collaborators
2 joint publications
Justin Cidado
2 joint publications
William McCoull
2 joint publications
Mathew J Garnett
2 joint publications
Patricia Jaaks
2 joint publications
Elizabeth A Coker
1 joint publications
Kate F Byth
1 joint publications
Shenghua Wen
1 joint publications
Jeffrey W Tyner
1 joint publications
Omid Tavana
1 joint publications
Gareth P Gregory
